The spectrum and changes of biopsy-proven kidney diseases in Chinese children

被引:6
|
作者
He, Guohua [1 ]
Tao, Liyuan [2 ]
Li, Chenglong [3 ]
Zhong, Xuhui [1 ]
Wang, Haibo [4 ]
Ding, Jie [1 ]
机构
[1] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China
[2] Peking Univ Third Hosp, Res Ctr Clin Epidemiol, Beijing, Peoples R China
[3] Peking Univ, Peking Univ First Hosp, Clin Res Inst, Beijing, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Clin Trial Unit, Guangzhou, Peoples R China
基金
中央高校基本科研业务费专项资金资助; 北京市自然科学基金;
关键词
Children; Biopsy; Pathology; SINGLE-CENTER EXPERIENCE; RENAL BIOPSY; GLOMERULAR-DISEASES; MORTALITY;
D O I
10.1007/s40620-022-01527-2
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aim The study aimed to investigate the spectrum of biopsy-proven kidney disease in Chinese children. Methods Records of children 0-17 years old who underwent native kidney biopsy from June 1st, 2013 to December 31st, 2018 in the national inpatients' database of China were analyzed. Biopsy-proven kidney diseases of different sex, age groups, and diagnosis, and the changing patterns of kidney disease compared with the previous study were analyzed. Results A total of 21,311 patients from 232 hospitals with a median age of 11.34 years were included. Immunoglobulin A vasculitis with nephritis (IgAVN) was the most common pathological finding [29.17%, 95% confidence interval (confidence interval, CI) = 28.56-29.78], followed by IgA nephropathy (IgAN) (22.70%, 95% CI = 22.14-23.27). IgAN was the most common finding in patients with hematuria (60.75%, 95% CI = 58.83-62.65], proteinuria (33.43%, 95% CI = 30.54-36.42), and hematuria plus proteinuria (62.77%, 95% CI = 56.19-69.02). Minimal change disease was the most common finding (40.69%, 95% CI = 39.41-41.98) in nephrotic syndrome. The proportion of IgAVN in patients with biopsy-proven glomerular disease increased year by year during 2013-2018 (p for trend < 0.001) and was higher than that of 2004-2014 [29.41% (95% CI = 29.10-29.72) in 2013-2018 vs. 13.35% (95% CI = 12.97-13.73) 2004-2014, p < 0.001]. The proportion of hepatitis B virus associated nephritis during 2013-2018 was lower than that of 2004-2014 [0.44% (95% CI = 0.36-0.54) in 2013-2018 vs. 0.87% (95% CI = 0.67-1.10) in 2004-2014, p < 0.001]. Conclusions IgAVN and IgAN were the most common types of pathological findings in children who underwent kidney biopsies from 2013 to 2018. The pathological spectrum of kidney biopsy changed over time.
引用
收藏
页码:417 / 427
页数:11
相关论文
共 50 条
  • [21] Epidemiologic data of adult native biopsy-proven renal diseases in Croatia
    Ivica Horvatic
    Miroslav Tisljar
    Stela Bulimbasic
    Borka Bozic
    Danica Galesic Ljubanovic
    Kresimir Galesic
    International Urology and Nephrology, 2013, 45 : 1577 - 1587
  • [22] Epidemiologic data of adult native biopsy-proven renal diseases in Croatia
    Horvatic, Ivica
    Tisljar, Miroslav
    Bulimbasic, Stela
    Bozic, Borka
    Ljubanovic, Danica Galesic
    Galesic, Kresimir
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2013, 45 (06) : 1577 - 1587
  • [23] Associations of urinary fetuin-A with histopathology and kidney events in biopsy-proven kidney disease
    Tsai, Ming-Tsun
    Tseng, Wei-Cheng
    Lee, Kuo-Hua
    Lin, Chih-Ching
    Ou, Shuo-Ming
    Li, Szu-yuan
    CLINICAL KIDNEY JOURNAL, 2024, 17 (04)
  • [24] SPECTRUM OF BIOPSY-PROVEN RENAL DISEASES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. A SINGLE CENTER STUDY
    Wagrowska-Danilewicz, Malgorzata
    Danilewicz, Marian
    POLISH JOURNAL OF PATHOLOGY, 2015, 66 (04) : 361 - 367
  • [25] Interleukin-2 Receptor Antagonist Does Not Decrease Biopsy-Proven Acute Rejection among Adult Chinese Kidney Transplant Recipients
    Lo, Ying-Chih
    Ho, Hao-Chung
    Wu, Ming-Ju
    Chen, Cheng-Hsu
    Cheng, Chi-Hung
    Yu, Tung-Min
    Chuang, Ya-Wen
    Huang, Shih-Ting
    Yang, Cheng-Kuang
    Shu, Kuo-Hsiung
    RENAL FAILURE, 2012, 34 (07) : 856 - 861
  • [26] Outcome in biopsy-proven Lupus nephritis: Evaluation of biopsies from the Norwegian Kidney Biopsy Registry
    Norby, G. E.
    Mjoen, G.
    Bjorneklett, R.
    Vikse, B. E.
    Holdaas, H.
    Svarstad, E.
    Aasarod, K.
    LUPUS, 2017, 26 (08) : 881 - 885
  • [27] The incidence of biopsy-proven glomerulonephritis in Australia
    Briganti, EM
    Dowling, J
    Finlay, M
    Hill, PA
    Jones, CL
    Kincaid-Smith, PS
    Sinclair, R
    McNeil, JJ
    Atkins, RC
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (07) : 1364 - 1367
  • [28] Real world outcomes of biopsy-proven oncocytic neoplasm of the kidney managed by surveillance
    Rodger, Flora E.
    Brown, Keiran
    Leung, Steve
    Coode-Bate, Jack
    Armitage, James
    Warren, Anne
    Hendry, Jane
    Stewart, Grant D.
    Laird, Alex
    Oades, Grenville M.
    BJUI COMPASS, 2022, 3 (04): : 291 - 297
  • [29] Clinicopathological spectrum of biopsy-proven renal diseases of patients at a single center in Sri Lanka: a cross sectional retrospective review
    Chanaka Muthukuda
    Vindika Suriyakumara
    Cherine Sosai
    Thilina Samarathunga
    Maithili Laxman
    Arjuna Marasinghe
    BMC Nephrology, 24
  • [30] Clinicopathological spectrum of biopsy-proven renal diseases of patients at a single center in Sri Lanka: a cross sectional retrospective review
    Muthukuda, Chanaka
    Suriyakumara, Vindika
    Sosai, Cherine
    Samarathunga, Thilina
    Laxman, Maithili
    Marasinghe, Arjuna
    BMC NEPHROLOGY, 2023, 24 (01)